BREVAGENPLUS

Welcome to the Brand page for “BREVAGENPLUS”, which is offered here for The mark consists of the term brevagenplus where the letters breva are black, the letters gen are pink and the letters plus. are teal. above and to the left of the term is a pink rectangular design.;diagnostic preparations and reagents for clinical and medical use; diagnostic test preparations comprised primarily of reagents and assays for clinical and medical use;breva gen plus;the color(s) pink, black and teal is/are claimed as a feature of the mark.;diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test preparations comprised primarily of reagents and assays for scientific use;medical diagnostic services, including reagent sample testing and diagnostic services for others in the fields of science and medical research; genetic testing for medical purposes, including genome mapping, genome analysis, and genome scanning;biotechnology research and development services for others, including genetic association studies, genome mapping, genome analysis and genome scanning, pharmaceutical drug and therapeutics development; product development, including consumer health product development and consultation in the field of genomics and pharmaceutical drug development;.

Its status is currently believed to be active. Its class is unavailable. “BREVAGENPLUS” is believed to be currently owned by “Genetic Technologies Limited”.


Owner:
GENETIC TECHNOLOGIES LIMITED
Owner Details
Description:
The mark consists of the term BREVAGENPLUS where the letters BREVA are black, the letters GEN are pink and the letters PLUS. are teal. Above and to the left of the term is a pink rectangular design.;Diagnostic preparations and reagents for clinical and medical use; diagnostic test preparations comprised primarily of reagents and assays for clinical and medical use;BREVA GEN PLUS;The color(s) pink, black and teal is/are claimed as a feature of the mark.;Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test preparations comprised primarily of reagents and assays for scientific use;Medical diagnostic services, including reagent sample testing and diagnostic services for others in the fields of science and medical research; genetic testing for medical purposes, including genome mapping, genome analysis, and genome scanning;Biotechnology research and development services for others, including genetic association studies, genome mapping, genome analysis and genome scanning, pharmaceutical drug and therapeutics development; product development, including consumer health product development and consultation in the field of genomics and pharmaceutical drug development;
Categories: